Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Biotechnology
Voyager Shares Take Off on Parkinson's Disease Development Deal
AbbVie to provide multi-million-dollar financing to Voyager to develop and commercialize potential Parkinson's treatment.
Bausch Health Swings to Loss but Revenue Tops Analysts' Expectations
Bausch Health swings to a loss in the fourth quarter but issues positive revenue guidance for fiscal 2019.
3 Small Biotechs to Watch as Earnings Season Winds Down
One already is up nicely on its results, while the other two should issue reports of interest in the next few days.
Medtronic Reports Strong Surgical Product Sales on Way to Earnings Beat
Medtronic raises its full-year earnings forecast above analysts' estimates.
Behind the Cutting Edge Technology: The History of Amgen
This biotechnology company got it's start California. Watch 'Behind the Label' TheStreet's new video series to learn more.
I Like These 2 Smaller Name Biotech Stocks
I still believe it will be a big year for buyouts across the biotech industry.
Moderna's Small Base Could Surprise on the Upside
Prices have moved above the early January high giving us the simple definition of an uptrend.
Incyte Expected to Earn 17 Cents a Share
Incyte revenue expected to rise 9.5% to $486.2 million.
Gilead Sciences Falls on Failed Cirrhosis Drug Trial of Selonsertib
Gilead Sciences says Selonsertib, a new drug for treating NASH, a type of liver disease, failed Phase 3 trials.
It's a Stock Picker's Delight Right Now
With cash levels high, those players who are not well-positioned for upside action are scrambling to put money to work and are helping to propel prices higher.